Mamta Sapra, MD

Department of Psychiatry, Salem Veteran Affairs Medical Center, Salem, Virginia; Virginia Tech Carilion School of Medicine, Roanoke, Virginia

  • 2Articles
  • 6.9KReads1
  • 2020–2025Active
  • 50Collaborators
  • 19Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Mamta Sapra, MD, is affiliated with the Department of Psychiatry at Salem Veteran Affairs Medical Center in Salem, Virginia, and Virginia Tech Carilion School of Medicine in Roanoke, Virginia. Sapra has published research on major depressive disorder, focusing on personalized treatment selection using deep-learning clinical decision support systems and the impact of co-occurring posttraumatic stress disorder on antipsychotic augmentation outcomes. Contributions span from 2020 to 2025 in peer-reviewed journals including Psychiatrist.com. Frequent collaborators include Alexandra Anacleto, Ali Iranmanesh, and Boadie W. Dunlop.

Publications

JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
Original Research

Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management

August 27, 2025

This study provides preliminary evidence that longitudinal use of an AI-enabled clinical decision support system can improve outcomes in MDD.
, , , et al
JCP
Original Research

Impact of Concurrent PTSD on Next-Step MDD Treatment

June 23, 2020

Can comorbid posttraumatic disorder (PTSD) affect treatment of depression? This study compared 3 next-step treatment options in veterans who had major depressive disorder with and without comorbid PTSD and...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe